Back

HIV-infected participants on combination ART (tenofovir, emtricitabine, efavirenz) have improved endothelial function and smaller retinal venular calibers compared to treatment naive participants

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Immunodeficiency virus (HIV) HIV and Cardiovascular Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Hans Strijdom

University of Stellenbosch, Cape Town (South Africa)

8 More presentations in this session

Presentation thumbnail
Effect of anthropometrics, serostatus, medication and cocaine use on quantified coronary plaque volumes in patients with human immunodeficiency virus
Doctor M. Kolossvary (Budapest, HU)
Abstract
Presentation thumbnail
Waist:Hip ratio (WHR): a better predictor of cardiovascular risk(CVR) than BMI in people living with HIV
Doctor R. Rakhit (London, GB)
Abstract Slides
Presentation thumbnail
Neutrophil-lymphocyte ratio and peripheral arterial disease in HIV infection
Doctor N. Ortega Zaragoza (Mexico City, MX)
Abstract
Presentation thumbnail
Atherosclerotic cardiovascular events in people living with Human Immunodeficiency Virus
Professor F. Boccara (Paris, FR)
Abstract Slides
Presentation thumbnail
Association between high-sensitive troponin I and subclinical coronary atherosclerosis in well-controlled HIV-infected adults
Doctor M. Vassara (Bangkok, TH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Immunodeficiency virus (HIV)

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources